CBAT | CorTronix Biomedical Proving It Does Have A Pulse

CBAT Stock, CBAT Stock Quote, Cortronix Biomedical Advancement TechnologiesYoel Palomino sure has his work cut out for him while he attempts to get his advanced telemetric system used to transmit, analyze, report and store all types and variations of physiological studies up off the ground – literally. For the second straight day, the penny stock of Cortronix Biomedical Advancement Technologies Inc. (OTC: CBAT) began the session by tanking hard and taking a slew of traders who got in on yesterday’s volume surge with it. For the moment, CBAT stock doesn’t look very attractive, but with a couple of fresh banana shakes and a pan con bistec or two, the Hialeah based, former Pana-Minerales S A (PNAM), ticker might just back that ask up and show a pulse.

Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!

CBAT, CBAT Stock, CBAT Stock Quote, CBAT Share Structure, CBAT Stock Review, Cortronix Biomedical Advancement Technologies Inc.,Cortronix,Cortronix Biomedical,Yoel Palomino,hot biotech stocks, biotech stocks under $1, biotech stocks under $5,Pana-Minerales S A,PNAMCBAT Stock Quote

Market Cap: 44.49M
Last: 0.155 ▼ -0.0050 (-3.13%)
Volume: 123,555
Dollar Volume: $17,651
Open: 0.15
High: 0.15
Low: 0.115
Trades: 17
Authorized: 800,000,000
Issued and Outstanding: 287,000,000
14-Day Rel Strength: 32.89%
14-Day Stochastic: 0.00%
1st Resistance Point: 0.2283
1st Support Level: 0.1183

Looking for Hot Penny Stocks?
here To Receive FREE Penny Stock Alerts

CorTronix looks like the typical start up from the POV of a product. They have spent their time and efforts into creating a complete product line that will consist of multiple revolutionary mobile devices with the capacity to acquire and process patient’s data through a consolidated “Single Source” Network.

Without revenues as of yet, CorTronix isn’t a bad set up from the view of their balance sheet. Since they acquired the technology from their sole director’s CorTronix Technologies back on September 11, 2012 for 175,000,000 restricted shares of CBAT stock, they haven’t really put themselves into too much debt.

For the 6 months ended February 28, 2013, the net loss incurred was only ($218,573).

As for CBAT stock itself, just like Monday when traders thought they were loading the boat by getting in deep with Dephasium Corp. (DPHS) when it was trading above 0.50, the -50% loss so far is nothing more than a typical attempt to get in front of a falling rock. However, even rocks that fall have been known to bounce which makes the action on CBAT intriguing enough to be monitored as the week closes out.

About CBAT Stock

CorTronix Biomedical Advancement Technologies, Inc.

Click here to view the SEC filings for CBAT.
Click here to view the website for CorTronix.

Last 5 Trading Sessions:

Date Last Change % Change Volume
06/05/13 0.1600 -0.0950 -37.25% 1,109,200
05/30/13 0.2550 -0.0250 -8.93% 300
05/22/13 0.2800 -0.0200 -6.67% 10,300
05/21/13 0.3000 unch unch 5,000
05/20/13 0.3000 +0.0150 +5.26% 10,000


facebookTwitterStay Connected With Us: 

Bottom Line:

Here’s a concept: You can get your hands on one of the Biozoom Inc. (BIZM) scanners, upload your results to your CBAT medical data storage product, get onto Yappn Corp. (YPPN) and start up a discussion board about your symptoms, and then get one of the Dephasium Corp. (DPHS) radiation blockers for your smartphone and be living the life of the hot penny stocks right now.

* Email

Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter

If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks

(We are 100% Anti-Spam and will never rent or sell your information)

Last updated by at .

  Recent Penny Stock News